Nuestra evidencia
| Status | Stage |
|---|---|
- Acupuncture for hypertension
- Advice to reduce dietary salt for prevention of cardiovascular disease
- Alcohol intake reduction for controlling hypertension
- Allied health professional-led interventions for improving control of blood pressure in patients with hypertension
- Alpha-lipoic acid for hypertension in adults
- Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension
- Angiotensin converting enzyme inhibitor induced angioedema in patients with primary hypertension
- Antihypertensive pharmacotherapy for prevention of sudden cardiac death in hypertensive individuals
- Antiplatelet agents and anticoagulants for hypertension
- Atorvastatin for lowering lipids
- Beta-blockers for hypertension
- Blood pressure lowering effect of diuretics as second line therapy for primary hypertension in crossover trials
- Blood pressure lowering effect of hydrochlorothiazide compared to other diuretics for hypertension
- Blood pressure lowering efficacy of alpha blockers for primary hypertension
- Blood pressure lowering efficacy of angiotensin converting enzyme (ACE) inhibitors for primary hypertension
- Blood pressure lowering efficacy of angiotensin receptor blockers for primary hypertension
- Blood pressure lowering efficacy of beta-1 selective beta blockers for primary hypertension
- Blood pressure lowering efficacy of beta-blockers as second-line therapy for primary hypertension
- Blood pressure lowering efficacy of calcium channel blockers for primary hypertension
- Blood pressure lowering efficacy of calcium-channel blockers as second-line therapy for primary hypertension
- Blood pressure lowering efficacy of clonidine for primary hypertension
- Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension
- Blood pressure lowering efficacy of diuretics as second-line therapy for primary hypertension
- Blood pressure lowering efficacy of drugs inhibiting the renin-angiotensin system as second-line therapy for primary hypertension
- Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension
- Blood pressure lowering efficacy of nonselective beta-blockers for primary hypertension
- Blood pressure lowering efficacy of partial agonist beta blocker monotherapy for primary hypertension
- Blood pressure lowering efficacy of potassium-sparing diuretics (that block the epithelial sodium channel) for primary hypertension
- Blood pressure lowering efficacy of renin inhibitors for primary hypertension
- Blood pressure targets for hypertension in older adults
- Blood pressure targets for hypertension in people with chronic renal diseaseNew
- Blood pressure targets for hypertension in people with diabetes mellitus
- Blood pressure targets for the treatment of people with hypertension and cardiovascular disease
- Blood pressure targets in adults with hypertension
- Blood pressure-lowering efficacy of loop diuretics for primary hypertension
- Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertension
- Blood pressure-lowering efficacy of reserpine for primary hypertension
- Calcium channel blockers versus other classes of drugs for hypertension
- Calcium supplementation for prevention of primary hypertension
- Calcium supplementation for the management of primary hypertension in adults
- Cerivastatin for lowering lipids
- Combined calcium, magnesium and potassium supplementation for the management of primary hypertension in adults
- Community and home-based exercise for the prevention and treatment of hypertension
- Cordyceps sinensis for hypertension in adults
- Creatine and creatine analogues in hypertension and cardiovascular disease
- Effect of adrenergic agonist oral decongestants on blood pressure
- Effect of alcohol on blood pressure
- Effect of amphetamines on blood pressure
- Effect of atorvastatin on testosterone levels
- Effect of cocoa on blood pressure
- Effect of cyclosporine on blood pressure
- Effect of early treatment with anti-hypertensive drugs on short and long-term mortality in patients with an acute cardiovascular event
- Effect of longer-term modest salt reduction on blood pressure
- Effect of periodontal treatments on blood pressure
- Effect of phosphodiesterase 5 inhibitors on blood pressure
- Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride
- Eplerenone for hypertension
- Evening versus morning dosing regimen drug therapy for hypertension
- Fermented milk for hypertension
- First-line beta-blockers versus other antihypertensive medications for chronic type B aortic dissection
- First-line combination therapy versus first-line monotherapy for primary hypertension
- First-line diuretics versus other classes of antihypertensive drugs for hypertension
- First-line drug classes for hypertension in adults: a network meta-analysis
- First-line drugs for hypertension
- First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension
- Fluvastatin for lowering lipids
- Garlic for the prevention of cardiovascular morbidity and mortality in hypertensive patients
- Hydralazine for essential hypertension
- Interaction of calcium channel blockers and grapefruit juice in healthy adults
- Interval training exercise for hypertension
- Interventions for improving adherence to treatment in patients with high blood pressure in ambulatory settings
- Interventions used to improve control of blood pressure in patients with hypertension
- Isometric exercise training for hypertension
- Long-term effects of weight-reducing diets in people with hypertension
- Long-term effects of weight-reducing drugs in people with hypertension
- Lovastatin for lowering lipids
- Magnesium supplementation for the management of primary hypertension in adults
- Methyldopa for primary hypertension
- Organisational interventions for improving control of blood pressure in individuals with hypertension
- Pharmacological interventions for hypertension in children
- Pharmacological interventions for hypertensive emergencies
- Pharmacotherapy for hypertension in adults 60 years or older
- Pharmacotherapy for hypertension in adults aged 18 to 59 years
- Pharmacotherapy for hypertension in adults with obstructive sleep apnea
- Pharmacotherapy for hypertension in women of different races
- Pharmacotherapy for hypertension-induced left ventricular hypertrophy
- Pharmacotherapy for hyperuricaemia in hypertensive patients
- Pharmacotherapy for mild hypertension
- Pharmacotherapy for resistant hypertension in adults
- Pitavastatin for lowering lipids
- Potassium supplementation for the management of primary hypertension in adults
- Pravastatin for lowering lipids
- Relaxation therapies for the management of primary hypertension in adults
- Renal denervation for resistant hypertension
- Renin inhibitors versus angiotensin converting enzyme (ACE) inhibitors for primary hypertension
- Renin inhibitors versus angiotensin receptor blockers for primary hypertension
- Renin-angiotensin system inhibitors for treating COVID-19 in adults
- Riboflavin supplements for blood pressure lowering in adults
- Roselle for hypertension in adults
- Rosuvastatin for lowering lipids
- Screening strategies for hypertension
- Self-monitoring for improving control of blood pressure in patients with hypertension
- Simvastatin for lowering lipids
- Spironolactone for hypertension
- Statins for preventing major vascular events in people with hypertension
- Tai Chi for hypertension
- Thiazide diuretics and the risk of hip fracture
- Tianma Gouteng Yin Formula for treating primary hypertension
- Time course for blood pressure lowering of angiotensin receptor blockers
- Time course for blood pressure lowering of angiotensin-converting-enzyme inhibitors
- Time course for blood pressure lowering of beta-blockers with partial agonist activity
- Time course for blood pressure lowering of dihydropyridine calcium channel blockers
- Time course for blood pressure lowering of thiazides
- Walking for hypertension
- Withdrawal of antihypertensive drugs in older people
- Hypertension as undesired effect of treatment (3)
- Prevention of Hypertension (20)
- Diet (10)
- Weight loss (0)
- Sodium/potassium/calcium intake (8)
- Calcium supplementation for the management of primary hypertension in adults
- Combined calcium, magnesium and potassium supplementation for the management of primary hypertension in adults
- Calcium supplementation for prevention of primary hypertension
- Effect of longer-term modest salt reduction on blood pressure
- Magnesium supplementation for the management of primary hypertension in adults
- Potassium supplementation for the management of primary hypertension in adults
- Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride
- Advice to reduce dietary salt for prevention of cardiovascular disease
- Garlic (1)
- Caffeine (0)
- Other (1)
- Lifestyle (4)
- Exercise (3)
- Alcohol intake (1)
- Tobacco use (0)
- Behavior Modification (5)
- Meditation (0)
- Relaxation response (1)
- Biofeedback (0)
- Advice (1)
- Adherence (1)
- Control (2)
- Preventive treatments (1)
- Diet (10)
- Treatment of essential Hypertension (130)
- Pharmacological Therapies (91)
- Aldosterone antagonists (2)
- General Pharmacotherapies (32)
- Blood pressure lowering efficacy of angiotensin converting enzyme (ACE) inhibitors for primary hypertension
- Alpha-lipoic acid for hypertension in adults
- Blood pressure lowering efficacy of angiotensin receptor blockers for primary hypertension
- Antiplatelet agents and anticoagulants for hypertension
- First-line combination therapy versus first-line monotherapy for primary hypertension
- Pharmacotherapy for mild hypertension
- Beta-blockers for hypertension
- Blood pressure lowering efficacy of renin inhibitors for primary hypertension
- Blood pressure targets for hypertension in older adults
- Blood pressure targets for the treatment of people with hypertension and cardiovascular disease
- Calcium channel blockers versus other classes of drugs for hypertension
- Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension
- Long-term effects of weight-reducing drugs in people with hypertension
- Pharmacotherapy for hyperuricaemia in hypertensive patients
- Antihypertensive pharmacotherapy for prevention of sudden cardiac death in hypertensive individuals
- Effect of phosphodiesterase 5 inhibitors on blood pressure
- Creatine and creatine analogues in hypertension and cardiovascular disease
- First-line drug classes for hypertension in adults: a network meta-analysis
- Evening versus morning dosing regimen drug therapy for hypertension
- Pharmacological interventions for hypertension in children
- Methyldopa for primary hypertension
- Pharmacological interventions for hypertensive emergencies
- Pharmacotherapy for hypertension in adults 60 years or older
- Pharmacotherapy for hypertension in adults with obstructive sleep apnea
- Statins for preventing major vascular events in people with hypertension
- Withdrawal of antihypertensive drugs in older people
- Blood pressure targets in adults with hypertension
- First-line drugs for hypertension
- Pharmacotherapy for hypertension in women of different races
- Pharmacotherapy for hypertension in adults aged 18 to 59 years
- Pharmacotherapy for hypertension-induced left ventricular hypertrophy
- Interventions for improving adherence to treatment in patients with high blood pressure in ambulatory settings
- Angiostensin-converting enzyme (ACE) inhibitors (7)
- Blood pressure lowering efficacy of angiotensin converting enzyme (ACE) inhibitors for primary hypertension
- Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension
- Angiotensin converting enzyme inhibitor induced angioedema in patients with primary hypertension
- Blood pressure lowering efficacy of drugs inhibiting the renin-angiotensin system as second-line therapy for primary hypertension
- Renin inhibitors versus angiotensin converting enzyme (ACE) inhibitors for primary hypertension
- Renin-angiotensin system inhibitors for treating COVID-19 in adults
- Time course for blood pressure lowering of angiotensin-converting-enzyme inhibitors
- Angiotensin receptor antagonists (6)
- Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension
- Blood pressure lowering efficacy of angiotensin receptor blockers for primary hypertension
- Blood pressure lowering efficacy of drugs inhibiting the renin-angiotensin system as second-line therapy for primary hypertension
- Renin inhibitors versus angiotensin receptor blockers for primary hypertension
- Renin-angiotensin system inhibitors for treating COVID-19 in adults
- Time course for blood pressure lowering of angiotensin receptor blockers
- Beta-adrenergic blocking agents (8)
- Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension
- Blood pressure lowering efficacy of beta-1 selective beta blockers for primary hypertension
- Beta-blockers for hypertension
- Blood pressure lowering efficacy of beta-blockers as second-line therapy for primary hypertension
- First-line beta-blockers versus other antihypertensive medications for chronic type B aortic dissection
- Time course for blood pressure lowering of beta-blockers with partial agonist activity
- Blood pressure lowering efficacy of nonselective beta-blockers for primary hypertension
- Blood pressure lowering efficacy of partial agonist beta blocker monotherapy for primary hypertension
- Calcium-channel blockers (5)
- Blood pressure lowering efficacy of calcium channel blockers for primary hypertension
- Blood pressure lowering efficacy of calcium-channel blockers as second-line therapy for primary hypertension
- Calcium channel blockers versus other classes of drugs for hypertension
- Interaction of calcium channel blockers and grapefruit juice in healthy adults
- Time course for blood pressure lowering of dihydropyridine calcium channel blockers
- Diuretics (9)
- Blood pressure lowering effect of diuretics as second line therapy for primary hypertension in crossover trials
- Blood pressure lowering effect of hydrochlorothiazide compared to other diuretics for hypertension
- Blood pressure lowering efficacy of diuretics as second-line therapy for primary hypertension
- Blood pressure-lowering efficacy of loop diuretics for primary hypertension
- Blood pressure lowering efficacy of potassium-sparing diuretics (that block the epithelial sodium channel) for primary hypertension
- Thiazide diuretics and the risk of hip fracture
- Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertension
- Time course for blood pressure lowering of thiazides
- First-line diuretics versus other classes of antihypertensive drugs for hypertension
- Alpha-adrenergic blockers (2)
- Central sympatholytics (2)
- Direct vasodilators (1)
- Herbs (3)
- Peripheral adrenergic neuron antagonists (0)
- Renin inhibitors (5)
- Blood pressure lowering efficacy of renin inhibitors for primary hypertension
- Blood pressure lowering efficacy of drugs inhibiting the renin-angiotensin system as second-line therapy for primary hypertension
- Renin inhibitors versus angiotensin converting enzyme (ACE) inhibitors for primary hypertension
- Renin inhibitors versus angiotensin receptor blockers for primary hypertension
- Renin-angiotensin system inhibitors for treating COVID-19 in adults
- Statins (9)
- Non-pharmacologic (22)
- Complementary and Alternative Treatments (2)
- Diet (10)
- Weight loss (1)
- Sodium/potassium/calcium intake (7)
- Calcium supplementation for the management of primary hypertension in adults
- Combined calcium, magnesium and potassium supplementation for the management of primary hypertension in adults
- Effect of longer-term modest salt reduction on blood pressure
- Magnesium supplementation for the management of primary hypertension in adults
- Potassium supplementation for the management of primary hypertension in adults
- Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride
- Advice to reduce dietary salt for prevention of cardiovascular disease
- Garlic (0)
- Caffeine (0)
- Other (2)
- Lifestyle (6)
- Exercise (5)
- Alcohol intake (1)
- Tobacco use (0)
- Behavior Modification (4)
- Meditation (0)
- Relaxation response (1)
- Biofeedback (0)
- Advice (1)
- Adherence (1)
- Control (1)
- Management/treatment of Specific sub-types of Hypertensive Patients (9)
- Adolescents and young adults (0)
- Children (1)
- Elderly patients (1)
- Non-pregnant female patients (1)
- Patients with isolated systolic hypertension (0)
- Patients with renal insufficiency (1)
- Patients with hypertension and cardiovascular history (stroke; angina pectoris; myocardial infarction; chronic peripheral vascular occlusive disease) (0)
- Patients with other cardiovascular risk factors (smoking; diabetes; high serum cholesterol levels; arterial fibrillation) (2)
- Resistant hypertension (1)
- Special Populations (2)
- Hypertensive Urgencies and Emergencies (2)
- Organization of Hypertension Services (6)
- Allied health professional-led interventions for improving control of blood pressure in patients with hypertension
- Organisational interventions for improving control of blood pressure in individuals with hypertension
- Screening strategies for hypertension
- Self-monitoring for improving control of blood pressure in patients with hypertension
- Interventions for improving adherence to treatment in patients with high blood pressure in ambulatory settings
- Interventions used to improve control of blood pressure in patients with hypertension
- Pharmacological Therapies (91)